Episode 102: Advancing Nursing Practice in Prostate Cancer Management: Clinical Evidence, Novel Agents, and Patient Care

Join UroNurse for a shared viewing of a webcast recorded at the Conversations in Primary Care: 2023 - Virtual Broadcast Live on May 20, 2023 and is being used with the permission of the presenters. 

Although effective treatments are available, many patients with prostate cancer eventually experience disease progression. As novel hormonal therapies and other emerging agents are introduced earlier in the disease course, treatment decision-making is becoming increasingly personalized, requiring consideration of novel risk factors, molecular imaging, and patient preferences as well as established clinical and pathological factors. Clinicians must be aware of the recent evidence regarding new therapies and combinations and be able to support and educate patients as they weigh the benefits and risks of systemic therapy.

This enduring activity is designed to meet the educational needs of urology nurses as well as advanced practice urology nurses, nurse practitioners, and oncology nurses involved in the treatment of patients with advanced prostate cancer.

This activity is supported by unrestricted grants from Astellas and Pfizer Inc., AstraZeneca, Bayer, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., Lantheus, Merck Sharp & Dohme LLC., and Novartis.

At the completion of viewing this you will be able to submit for free 1.00 / ANCC Contact Hour

*The information provided on the site is for educational purposes only, and does not substitute for professional medical advice. Consult a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment.